The SSP for Fluoxetine 40mg capsules has been extended until 10th August 2020.
This SSP was originally in place until 20th July, but has been extended. This may be outlines procedures to follow in providing a suitable alternative product, two Fluoxetine 20mg capsules in response to the serious shortage affecting the 40 mg capsules. Pharmacists must exercise their professional judgement when considering whether the alternative product is suitable for the patient.
Please ensure you are familiar with the current SSP before supplying the alternative product, and ensure your pharmacy team is aware of the changes.